Public Health Screening in an Era of Diagnostic Abundance (Preprint)
Authors:
- John O'DOnoghueJOJohn O'DOnoghue
- Tara AnanthesayananTATara Ananthesayanan
- Kayode Philip FadahunsiKFKayode Philip Fadahunsi
Preprint
- 7 September 2026
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
UNSTRUCTURED Population screening developed in an era when diagnostic information was constrained by the cost of testing, laboratory capacity, specialist interpretation, and healthcare infrastructure. Home diagnostics, point-of-care testing, wearable technologies, artificial intelligence (AI), and connected digital health systems are changing these conditions. We introduce the concept of diagnostic abundance to describe a transition in which the generation and availability of health-relevant diagnostic information are becoming progressively less constrained by traditional limitations of location, infrastructure, cost, and specialist interpretation. Diagnostic abundance does not imply universal or equitable access; diagnostic abundance and diagnostic scarcity can coexist between countries, within health systems, and across populations. Rather, the concept highlights a shift in the central problem facing screening: from obtaining diagnostic information toward determining which information is meaningful, trustworthy, actionable, and beneficial. We argue that increasingly abundant but fragmented diagnostic information creates opportunities for earlier detection, risk-based screening, expanded participation, and stronger public health intelligence, while also intensifying risks of overdiagnosis, false-positive findings, unnecessary follow-up, inequity, privacy loss, and health-system overload. To translate diagnostic abundance into public health value, we propose a diagnostic abundance value chain linking data generation to action and identify three foundations for responsible implementation: governance, interoperability, and enabling infrastructure. The next generation of screening policy should therefore focus not only on what can be screened, but on how increasingly abundant diagnostic information can be governed, integrated, interpreted, and translated into equitable public health benefit.Keywords
This publication has 28 references indexed in Scilit:
- Health Data with the European Health Data Space (EHDS)2026
- The Lancet Commission on diagnostics: advancing equitable access to diagnosticsThe Lancet, 2019
- Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic reviewPreventive Medicine, 2019
- Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United StatesJAMA Internal Medicine, 2018
- FHIR2018
- Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus PhotographsJAMA, 2016
- SNOMED CT Basics2015
- Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trialsEuropean Journal of Cancer, 2015
- Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trialThe Lancet Global Health, 2015
- Point-of-Care Testing2012